Rady Children's Specialists of San Diego
Rady Children's Specialists
University of North Carolina at Chapel Hill
Univ of Colorado - Denver
Univ of Colorado - Denver
Dr. Jane C. Burns is the director of the Kawasaki Disease Clinic at Rady Children's Hospital-San Diego and the Kawasaki Disease Research Center at UC San Diego. She is also a professor of pediatrics at UC San Diego School of Medicine.
After earning her medical degree at the University of North Carolina in Chapel Hill in 1978, she completed her pediatric residency and fellowship at the University of Colorado in Denver, followed by additional training in pediatric infectious diseases and molecular virology at Harvard Medical School and Boston Children's Hospital. She joined the faculty at Harvard Medical School in 1986 and moved to San Diego in 1990.
Internationally known for her research on Kawasaki disease (KD), her passion for studying KD has spanned almost three decades, with her first publication in 1982. In addition to her academic pursuits, Dr. Burns is the mother of two daughters. Her husband, John B. Gordon M.D., is an interventional cardiologist who cares for adults with long-term sequelae of KD. Together, working with a team from UC San Diego, they launched the Adult KD Collaborative, a long-range epidemiologic and clinical study of cardiovascular biomarkers and functional studies in adults who suffered from KD in childhood.
Urotensin 2 in Kawasaki disease pathogenesis.
Huang CY, Burns JC, Shimizu C
Assessment of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of Computerized Tomography Angiograms.
Grande Gutierrez N, Shirinsky O, Gagarina N, Lyskina G, Fukazawa R, Ogawa S, Burns JC, Marsden AL, Kahn AM
High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease.
Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, Tremoulet AH
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention.
Usefulness of Calcium Scoring as a Screening Examination in Patients With a History of Kawasaki Disease.
Kahn AM, Budoff MJ, Daniels LB, Oyamada J, Gordon JB, Burns JC
Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility.
Kim J, Shimizu C, Kingsmore SF, Veeraraghavan N, Levy E, Ribeiro Dos Santos AM, Yang H, Flatley J, Hoang LT, Hibberd ML, Tremoulet AH, Harismendy O, Ohno-Machado L, Burns JC
PRINCESS: Privacy-protecting Rare disease International Network Collaboration via Encryption through Software guard extensionS.
Chen F, Wang S, Jiang X, Ding S, Lu Y, Kim J, Sahinalp SC, Shimizu C, Burns JC, Wright VJ, Png E, Hibberd ML, Lloyd DD, Yang H, Telenti A, Bloss CS, Fox D, Lauter K, Ohno-Machado L
Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
Wang Y, Li Z, Hu G, Hao S, Deng X, Huang M, Ren M, Jiang X, Kanegaye JT, Ha KS, Lee J, Li X, Jiang X, Yu Y, Tremoulet AH, Burns JC, Whitin JC, Shin AY, Sylvester KG, McElhinney DB, Cohen HJ, Ling XB, Pediatric Emergency Medicine Kawasaki Disease Research Group.
miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.
He M, Chen Z, Martin M, Zhang J, Sangwung P, Woo B, Tremoulet AH, Shimizu C, Jain MK, Burns JC, Shyy JY
Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients.
Lee AM, Burns JC, Tremoulet AH
Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities.
Shimizu C, Eleftherohorinou H, Wright VJ, Kim J, Alphonse MP, Perry JC, Cimaz R, Burgner D, Dahdah N, Hoang LT, Khor CC, Salgado A, Tremoulet AH, Davila S, Kuijpers TW, Hibberd ML, Johnson TA, Takahashi A, Tsunoda T, Kubo M, Tanaka T, Onouchi Y, Yeung RS, Coin LJ, Levin M, Burns JC, International Kawasaki Disease Genetics Consortium.
Extreme giant aneurysms of three coronary arteries causing heart failure as late sequelae of Kawasaki disease.
Ammirati E, Burns JC, Moreo A, Daniels LB, Oliva F
Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.
Burns JC, KonÃ©-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW
Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
Connelly MA, Shimizu C, Winegar DA, Shalaurova I, Pourfarzib R, Otvos JD, Kanegaye JT, Tremoulet AH, Burns JC
Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children.
Herberg JA, Kaforou M, Wright VJ, Shailes H, Eleftherohorinou H, Hoggart CJ, Cebey-LÃ³pez M, Carter MJ, Janes VA, Gormley S, Shimizu C, Tremoulet AH, Barendregt AM, Salas A, Kanegaye J, Pollard AJ, Faust SN, Patel S, Kuijpers T, MartinÃ³n-Torres F, Burns JC, Coin LJ, Levin M, IRIS Consortium.
Kawasaki Disease and Exposure to Fine Particulate Air Pollution.
Zeft AS, Burns JC, Yeung RS, McCrindle BW, Newburger JW, Dominguez SR, Anderson MS, Arrington C, Shulman ST, Yoon J, Tewelde H, Mix C, Pope CA
A Classification Tool for Differentiation of Kawasaki Disease from OtherÂ Febrile Illnesses.
Hao S, Jin B, Tan Z, Li Z, Ji J, Hu G, Wang Y, Deng X, Kanegaye JT, Tremoulet AH, Burns JC, Cohen HJ, Ling XB, Pediatric Emergency Medicine KawasakiÂ DiseaseÂ Research Group.
A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease.
Whitin JC, Yu TT, Ling XB, Kanegaye JT, Burns JC, Cohen HJ
Adjunctive therapies for Kawasaki disease.
Campbell AJ, Burns JC
Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
Tremoulet AH, Jain S, Kim S, Newburger J, Arditi M, Franco A, Best B, Burns JC
Newburger JW, Takahashi M, Burns JC
The Spectrum of Cardiovascular Lesions Requiring Intervention in Adults After Kawasaki Disease.
Gordon JB, Daniels LB, Kahn AM, Jimenez-Fernandez S, Vejar M, Numano F, Burns JC
Letter by Daniels and Burns Regarding Article, "Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A Decade in Review".
Daniels LB, Burns JC
Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype.
Haddock ES, Calame A, Shimizu C, Tremoulet AH, Burns JC, Tom WL
See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.
Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at firstname.lastname@example.org.